P2.01-33 Open-Label, Biomarker-Directed Platform Study in NSCLC Patients Who Progressed on an Anti-PD-(L)1 Containing Therapy (HUDSON)

Authors :: Philip J. Jewsbury
Wolfram Brugger
Patrick M. Forde
Sabina Patel
Helen Ambrose
Kwang Bo Park
Peter G. Mortimer
Naiyer A. Rizvi
John V. Heymach
Michael Thomas
Si-Houy Lao-Sirieix
Glenwood D. Goss
B. Koetz
Mark M. Awad
Benjamin Besse
Kris Sachsenmeier
Source :: Journal of Thoracic Oncology. 13:S677
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Subjects :: Pulmonary and Respiratory Medicine
Oncology
medicine.medical_specialty
business.industry
Internal medicine
Biomarker (medicine)
Medicine
Open label
business

Tools